[1]
2026. POTENTIAL OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG DERIVATIVES FOR BLOOD GLUCOSE REGULATION IN TYPE 2 DIABETES MELLITUS. DA NANG JOURNAL OF MEDICINE AND PHARMACY. 2, 1 (Mar. 2026), 26–37.